Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2022

Upgrades

According to Gordon Haskett, the prior rating for Williams-Sonoma Inc WSM was changed from Hold to Accumulate. Williams-Sonoma earned $3.32 in the third quarter, compared to $2.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $223.32 and a 52-week-low of $118.07. Williams-Sonoma closed at $163.67 at the end of the last trading period.

For Lowe's Companies Inc LOW, Gordon Haskett upgraded the previous rating of Accumulate to Buy. In the third quarter, Lowe's Companies showed an EPS of $2.73, compared to $1.98 from the year-ago quarter. The current stock performance of Lowe's Companies shows a 52-week-high of $263.31 and a 52-week-low of $150.84. Moreover, at the end of the last trading period, the closing price was at $233.66.

Daiwa Capital upgraded the previous rating for American Express Co AXP from Hold to Buy. In the fourth quarter, American Express showed an EPS of $2.18, compared to $1.76 from the year-ago quarter. The current stock performance of American Express shows a 52-week-high of $198.72 and a 52-week-low of $126.08. Moreover, at the end of the last trading period, the closing price was at $196.40.

Gordon Haskett upgraded the previous rating for Burlington Stores Inc BURL from Accumulate to Buy. For the third quarter, Burlington Stores had an EPS of $1.36, compared to year-ago quarter EPS of $0.29. The current stock performance of Burlington Stores shows a 52-week-high of $357.34 and a 52-week-low of $206.70. Moreover, at the end of the last trading period, the closing price was at $233.04.

Craig-Hallum upgraded the previous rating for Nautilus Inc NLS from Hold to Buy. The current stock performance of Nautilus shows a 52-week-high of $31.38 and a 52-week-low of $4.52. Moreover, at the end of the last trading period, the closing price was at $5.77.

According to WBB Securities, the prior rating for Paratek Pharmaceuticals Inc PRTK was changed from Buy to Strong Buy. Paratek Pharmaceuticals earned $0.37 in the third quarter, compared to $0.46 in the year-ago quarter. The stock has a 52-week-high of $11.23 and a 52-week-low of $3.54. At the end of the last trading period, Paratek Pharmaceuticals closed at $3.97.

For Tenet Healthcare Corp THC, UBS upgraded the previous rating of Neutral to Buy. In the fourth quarter, Tenet Healthcare showed an EPS of $2.70, compared to $4.72 from the year-ago quarter. The stock has a 52-week-high of $83.69 and a 52-week-low of $48.20. At the end of the last trading period, Tenet Healthcare closed at $82.22.

B of A Securities upgraded the previous rating for Scorpio Tankers Inc STNG from Underperform to Neutral. In the third quarter, Scorpio Tankers showed an EPS of $1.39, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of $24.67 and a 52-week-low of $11.02. Scorpio Tankers closed at $14.63 at the end of the last trading period.

According to Baird, the prior rating for Ambarella Inc AMBA was changed from Neutral to Outperform. In the third quarter, Ambarella showed an EPS of $0.57, compared to $0.09 from the year-ago quarter. The stock has a 52-week-high of $227.59 and a 52-week-low of $82.59. At the end of the last trading period, Ambarella closed at $151.72.

For HeadHunter Group PLC HHR, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, HeadHunter Group showed an EPS of $0.54, compared to $0.20 from the year-ago quarter. At the moment, the stock has a 52-week-high of $68.18 and a 52-week-low of $30.63. HeadHunter Group closed at $47.97 at the end of the last trading period.

JP Morgan upgraded the previous rating for Cogent Communications Holdings Inc CCOI from Neutral to Overweight. In the third quarter, Cogent Comms Hldgs showed an EPS of $0.28, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $80.50 and a 52-week-low of $56.80. Cogent Comms Hldgs closed at $65.65 at the end of the last trading period.

According to BMO Capital, the prior rating for Crown Holdings Inc CCK was changed from Market Perform to Outperform. For the fourth quarter, Crown Holdings had an EPS of $1.66, compared to year-ago quarter EPS of $1.50. At the moment, the stock has a 52-week-high of $118.05 and a 52-week-low of $92.41. Crown Holdings closed at $115.25 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

For Kohl's Corp KSS, Gordon Haskett downgraded the previous rating of Buy to Accumulate. Kohl's earned $1.65 in the third quarter, compared to $0.01 in the year-ago quarter. The current stock performance of Kohl's shows a 52-week-high of $64.80 and a 52-week-low of $43.67. Moreover, at the end of the last trading period, the closing price was at $61.96.

According to Gordon Haskett, the prior rating for Citi Trends Inc CTRN was changed from Buy to Accumulate. In the third quarter, Citi Trends showed an EPS of $1.03, compared to $0.67 from the year-ago quarter. At the moment, the stock has a 52-week-high of $111.44 and a 52-week-low of $41.48. Citi Trends closed at $45.84 at the end of the last trading period.

According to Wolfe Research, the prior rating for American International Group Inc AIG was changed from Outperform to Peer Perform. In the third quarter, American Intl Gr showed an EPS of $0.97, compared to $0.81 from the year-ago quarter. The current stock performance of American Intl Gr shows a 52-week-high of $63.54 and a 52-week-low of $41.17. Moreover, at the end of the last trading period, the closing price was at $62.41.

For EMCORE Corp EMKR, Lake Street downgraded the previous rating of Buy to Hold. EMCORE earned $0.14 in the first quarter, compared to $0.11 in the year-ago quarter. At the moment, the stock has a 52-week-high of $10.87 and a 52-week-low of $5.19. EMCORE closed at $5.89 at the end of the last trading period.

For Ross Stores Inc ROST, Gordon Haskett downgraded the previous rating of Accumulate to Hold. Ross Stores earned $1.09 in the third quarter, compared to $1.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $134.22 and a 52-week-low of $92.10. Ross Stores closed at $97.42 at the end of the last trading period.

According to B. Riley Securities, the prior rating for Quantum Corp QMCO was changed from Buy to Neutral. For the third quarter, Quantum had an EPS of $0.07, compared to year-ago quarter EPS of $0.00. The current stock performance of Quantum shows a 52-week-high of $9.47 and a 52-week-low of $4.35. Moreover, at the end of the last trading period, the closing price was at $4.95.

For 2U Inc TWOU, William Blair downgraded the previous rating of Outperform to Market Perform. For the fourth quarter, 2U had an EPS of $0.20, compared to year-ago quarter EPS of $0.06. At the moment, the stock has a 52-week-high of $59.74 and a 52-week-low of $13.12. 2U closed at $17.98 at the end of the last trading period.

According to Berenberg, the prior rating for 2U Inc TWOU was changed from Buy to Hold. In the fourth quarter, 2U showed an EPS of $0.20, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $59.74 and a 52-week-low of $13.12. At the end of the last trading period, 2U closed at $17.98.

Oppenheimer downgraded the previous rating for Quantum Corp QMCO from Outperform to Perform. For the third quarter, Quantum had an EPS of $0.07, compared to year-ago quarter EPS of $0.00. The current stock performance of Quantum shows a 52-week-high of $9.47 and a 52-week-low of $4.35. Moreover, at the end of the last trading period, the closing price was at $4.95.

For Intevac Inc IVAC, Benchmark downgraded the previous rating of Buy to Hold. In the fourth quarter, Intevac showed an EPS of $0.29, compared to $0.05 from the year-ago quarter. The stock has a 52-week-high of $8.46 and a 52-week-low of $3.93. At the end of the last trading period, Intevac closed at $5.63.

For Li-Cycle Holdings Corp LICY, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. For the fourth quarter, Li-Cycle Holdings had an EPS of $0.33, compared to year-ago quarter EPS of $0.05. The current stock performance of Li-Cycle Holdings shows a 52-week-high of $14.28 and a 52-week-low of $6.34. Moreover, at the end of the last trading period, the closing price was at $8.27.

For TTM Technologies Inc TTMI, Truist Securities downgraded the previous rating of Buy to Hold. For the fourth quarter, TTM Technologies had an EPS of $0.34, compared to year-ago quarter EPS of $0.37. The stock has a 52-week-high of $15.89 and a 52-week-low of $11.73. At the end of the last trading period, TTM Technologies closed at $14.33.

According to Barclays, the prior rating for Zynga Inc ZNGA was changed from Overweight to Equal-Weight. In the fourth quarter, Zynga showed an EPS of $0.09, compared to $0.09 from the year-ago quarter. At the moment, the stock has a 52-week-high of $12.32 and a 52-week-low of $5.57. Zynga closed at $9.17 at the end of the last trading period.

Jefferies downgraded the previous rating for Healthcare Services Group Inc HCSG from Hold to Underperform. For the fourth quarter, Healthcare Services Group had an EPS of $0.03, compared to year-ago quarter EPS of $0.37. The current stock performance of Healthcare Services Group shows a 52-week-high of $34.33 and a 52-week-low of $14.80. Moreover, at the end of the last trading period, the closing price was at $16.97.

For Sun Life Financial Inc SLF, National Bank Of Canada downgraded the previous rating of Outperform to Sector Perform. In the fourth quarter, Sun Life Financial showed an EPS of $1.21, compared to $1.13 from the year-ago quarter. The current stock performance of Sun Life Financial shows a 52-week-high of $58.49 and a 52-week-low of $47.85. Moreover, at the end of the last trading period, the closing price was at $58.25.

For Compass Minerals International Inc CMP, JP Morgan downgraded the previous rating of Neutral to Underweight. Compass Minerals Intl earned $0.38 in the fourth quarter, compared to $0.62 in the year-ago quarter. The current stock performance of Compass Minerals Intl shows a 52-week-high of $75.44 and a 52-week-low of $47.10. Moreover, at the end of the last trading period, the closing price was at $52.99.

For U.S. Xpress Enterprises Inc USX, JP Morgan downgraded the previous rating of Neutral to Underweight. In the fourth quarter, U.S. Xpress Enterprises showed an EPS of $0.03, compared to $0.15 from the year-ago quarter. The stock has a 52-week-high of $12.33 and a 52-week-low of $4.05. At the end of the last trading period, U.S. Xpress Enterprises closed at $4.42.

See all analyst ratings downgrades.

Initiations

Maxim Group initiated coverage on Inuvo Inc INUV with a Buy rating. The price target for Inuvo is set to $1.25. For the third quarter, Inuvo had an EPS of $0.02, compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $2.05 and a 52-week-low of $0.35. At the end of the last trading period, Inuvo closed at $0.47.

With a Buy rating, EF Hutton initiated coverage on Stran & Co Inc STRN. The price target seems to have been set at $5.50 for Stran & Co. The stock has a 52-week-high of $6.99 and a 52-week-low of $1.72. At the end of the last trading period, Stran & Co closed at $1.88.

SVB Leerink initiated coverage on 2seventy bio Inc TSVT with an Outperform rating. The price target for 2seventy bio is set to $38.00. At the moment, the stock has a 52-week-high of $64.00 and a 52-week-low of $13.77. 2seventy bio closed at $16.27 at the end of the last trading period.

Barclays initiated coverage on Constellation Energy Corp CEG with an Overweight rating. The price target for Constellation Energy is set to $52.00. The stock has a 52-week-high of $56.57 and a 52-week-low of $43.88. At the end of the last trading period, Constellation Energy closed at $47.31.

BMO Capital initiated coverage on Gold Royalty Corp GROY with a Market Perform rating. The current stock performance of Gold Royalty shows a 52-week-high of $7.08 and a 52-week-low of $3.39. Moreover, at the end of the last trading period, the closing price was at $4.39.

Morgan Stanley initiated coverage on Eventbrite Inc EB with a Equal-Weight rating. The price target for Eventbrite is set to $18.00. At the moment, the stock has a 52-week-high of $26.52 and a 52-week-low of $12.60. Eventbrite closed at $15.66 at the end of the last trading period.

Needham initiated coverage on Merus NV MRUS with a Buy rating. The price target for Merus is set to $45.00. For the third quarter, Merus had an EPS of $0.39, compared to year-ago quarter EPS of $0.64. The current stock performance of Merus shows a 52-week-high of $33.09 and a 52-week-low of $16.14. Moreover, at the end of the last trading period, the closing price was at $26.14.

With an Overweight rating, Wells Fargo initiated coverage on Kymera Therapeutics Inc KYMR. The price target seems to have been set at $62.00 for Kymera Therapeutics. For the third quarter, Kymera Therapeutics had an EPS of $0.56, compared to year-ago quarter EPS of $0.39. At the moment, the stock has a 52-week-high of $76.01 and a 52-week-low of $29.93. Kymera Therapeutics closed at $43.18 at the end of the last trading period.

With a Equal-Weight rating, Wells Fargo initiated coverage on Nurix Therapeutics Inc NRIX. The price target seems to have been set at $28.00 for Nurix Therapeutics. In the fourth quarter, Nurix Therapeutics showed an EPS of $0.85, compared to $0.51 from the year-ago quarter. At the moment, the stock has a 52-week-high of $47.84 and a 52-week-low of $16.67. Nurix Therapeutics closed at $19.69 at the end of the last trading period.

With an Overweight rating, Wells Fargo initiated coverage on Arvinas Inc ARVN. The price target seems to have been set at $98.00 for Arvinas. Arvinas earned $0.94 in the third quarter, compared to $0.79 in the year-ago quarter. The stock has a 52-week-high of $108.47 and a 52-week-low of $56.59. At the end of the last trading period, Arvinas closed at $74.68.

Wells Fargo initiated coverage on Monte Rosa Therapeutics Inc GLUE with a Equal-Weight rating. The price target for Monte Rosa Therapeutics is set to $19.00. In the third quarter, Monte Rosa Therapeutics showed an EPS of $0.43, compared to $4.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $45.56 and a 52-week-low of $9.82. Monte Rosa Therapeutics closed at $15.09 at the end of the last trading period.

With a Equal-Weight rating, Wells Fargo initiated coverage on C4 Therapeutics Inc CCCC. The price target seems to have been set at $25.00 for C4 Therapeutics. For the third quarter, C4 Therapeutics had an EPS of $0.51, compared to year-ago quarter EPS of $17.55. The current stock performance of C4 Therapeutics shows a 52-week-high of $51.21 and a 52-week-low of $19.83. Moreover, at the end of the last trading period, the closing price was at $24.51.

See all analyst ratings initiations.